Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-02 18:48:04 - browse：2396

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Judge rejects Trump's request to move Stormy Daniels hush

WSS

How AI helped researchers track recovery from depression

7 more heat

Senators: Long

Mass General totes up its waste in a move to tackle climate change

Why are Kaiser Permanente staff considering a strike?

Tocagen's brain cancer gene therapy trial continues. Investors worry

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

After affirmative action ruling, medical educators look to 'holistic review'

Mass General totes up its waste in a move to tackle climate change

Bright Health sells Medicare Advantage business to Molina

Study identifies new proteins linked to dementia risk 25 years later

Medicare details structure of new drug price negotiation program

Experts study whether long Covid risk adds up with each reinfection

George Santos makes 1st court appearance after pleading not guilty to 13 counts

7 more heat

hotspot

Mass General totes up its waste in a move to tackle climate change

Senators: Long

Ending racial health disparities hinges on penalties, political will

Vir antibody drug aimed at influenza A fails in clinical trial

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Hospitals struggle to profit from CAR

knowledge

hotspot

leisure time

focus